Ethics declarations Ethics approval and consent to participate All methods were carried out in accordance with relevant guidelines and regulations
Their ability to promote weight loss and glycemic control is comparable, Dr
9 Common Questions." FDA: "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss," "Label: Foundayo (Orforglipron)." National Association of Insurance Commissioners: "Does Insurance Cover Prescription Weight Loss Injectables?" University of Chicago Medicine: "Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns." Massachusetts General Hospital: "Preserving Lean Body Mass in Patients Taking GLP-1 for Weight Loss." UT Southwestern Medical Center: "Weight-loss medications: The 5 most-asked questions." University of Kansas Health System: "Surprises and Concerns About GLP-1 Medications." Brown University Health: "Compounded Weight Loss Medications: What are They and What are Their Risks?" University of Missouri Health: "Thinking About Microdosing GLP-1
Reports indicate that calls to poison control related to these medications have risen sharply in recent years, raising concerns about dosing errors, misuse, and accidental exposure as the drugs become more prevalent in households
While GLP-1 medications primarily target appetite regulation and weight loss, they may also have an indirect effect on hormonal imbalances, influencing how the body responds to food cravings
